{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:53:00Z","timestamp":1792979580002,"version":"4.5.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a highly aggressive liver cancer with a rising incidence globally. Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized HCC treatment, yet response rates remain variable. Sex-based disparities in immunotherapy efficacy have become increasingly recognized as important factors influencing treatment outcomes in HCC. This review examines the role of biological sex in HCC progression and immunotherapy responses. It discusses the epidemiology of sex differences in HCC incidence, prognosis, and therapeutic outcomes, highlighting the impact of sex hormones, such as estrogen and testosterone, on immune system function and tumor biology. Estrogen\u2019s protective effects, including enhanced T cell activation and improved immune surveillance, contribute to better treatment responses in females, while testosterone\u2019s immunosuppressive effects lead to poorer outcomes in males. The review also explores the influence of the tumor microenvironment, including immune cell composition and macrophage polarization, on treatment efficacy. Emerging evidence suggests that sex-specific factors, including hormonal status, should be considered in clinical trials and personalized treatment strategies. By addressing these disparities, tailored immunotherapeutic approaches could optimize efficacy and minimize toxicity in both male and female HCC patients, ultimately improving overall outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1607374","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:39:08Z","timestamp":1747201148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy"],"prefix":"10.3389","volume":"16","author":[{"given":"Lei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0402","article-title":"Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective","volume":"29","author":"Xie","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: The growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108387","article-title":"Immunotherapy for hepatocellular carcinoma: Recent advances and future targets","volume":"244","author":"Yu","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001875","article-title":"Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003441","article-title":"Off-the-shelf Vdelta1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma","volume":"9","author":"Makkouk","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02894-y","article-title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial","volume":"30","author":"Yarchoan","year":"2024","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-021-01467-8","article-title":"Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion","volume":"20","author":"Cai","year":"2021","journal-title":"Mol Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2630","article-title":"Androgen conspires with the CD8(+) T cell exhaustion program and contributes to sex bias in cancer","volume":"7","author":"Kwon","year":"2022","journal-title":"Sci Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30261-4","article-title":"Cancer immunotherapy efficacy and patients\u2019 sex: a systematic review and meta-analysis","volume":"19","author":"Conforti","year":"2018","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-1829","article-title":"Sex hormones in breast cancer immunity","volume":"83","author":"Hargrove-Wiley","year":"2023","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-3966","article-title":"Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development","volume":"84","author":"He","year":"2024","journal-title":". Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23396","article-title":"Estrogen receptor-alpha36 is involved in diallyl sulfide-induced inhibition of Malignant growth of HepG2 and Huh7 hepatocellular carcinoma cells","volume":"37","author":"Wu","year":"2022","journal-title":"Environ Toxicol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13768","DOI":"10.3390\/ijms232213768","article-title":"X Constitutively active androgen receptor in hepatocellular carcinoma","volume":"23","author":"Montgomery","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-016-9043-9","article-title":"Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms","volume":"60","author":"Zheng","year":"2017","journal-title":"Sci China Life Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.01.055","article-title":"Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment","volume":"419","author":"Manka","year":"2018","journal-title":"Cancer Lett"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.3390\/ijms20205220","article-title":"oles of thyroid hormone-associated microRNAs affecting oxidative stress in human hepatocellular carcinoma","volume":"20","author":"Huang","year":"2019","journal-title":"R Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33699","article-title":"Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men","volume":"149","author":"Long","year":"2021","journal-title":". Int J Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.3390\/ijms22083820","article-title":"Sex and race-related DNA methylation changes in hepatocellular carcinoma","volume":"22","author":"Ye","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.10.009","article-title":"Sex differences in genomic features of hepatitis B-associated hepatocellular carcinoma with distinct antitumor immunity","volume":"15","author":"Xu","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100982","article-title":"A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma","volume":"6","author":"Balcar","year":"2024","journal-title":"JHEP Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","article-title":"Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectab le Disease with Enhanced Antitumor Immunity","volume":"2","author":"Ho","year":"2021","journal-title":"Nat Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectab le hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170809","article-title":"The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression","volume":"134","author":"Lafront","year":"2024","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00604-3","article-title":"Therapeutic resistance to anti-oestrogen therapy in breast cancer","volume":"23","author":"Will","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155412","article-title":"Formononetin attenuates psoriasiform inflammation by regulating interferon signaling pathway","volume":"128","author":"Xu","year":"2024","journal-title":"Phytomedicine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000288","article-title":"Immunology of neuromyelitis optica during pregnancy","volume":"3","author":"Davoudi","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S2090-1232(24)00622-2","DOI":"10.1016\/j.jare.2024.12.043","article-title":"Targeting macrophages in cancer immunotherapy: Frontiers and challenges","author":"Liu","year":"2025","journal-title":"J Adv Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41392-023-01365-z","article-title":"Emerging phagocytosis checkpoints in cancer immunotherapy","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303188","article-title":"Estradiol promotes M1-like macrophage activation through cadherin-11 to aggravate temporomandibular joint inflammation in rats","volume":"194","author":"Kou","year":"2015","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.599869","article-title":"Androgen receptor is dispensable for X-zone regression in the female adrenal but regulates post-partum corticosterone levels and protects cortex integrity","volume":"11","author":"Gannon","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00639-2","article-title":"YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior","volume":"53","author":"Jeon","year":"2021","journal-title":"Exp Mol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01008-22","article-title":"Modulation of SOCS3 Levels via STAT3 and Estrogen-ERalphap66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells","volume":"96","author":"Sooryanarain","year":"2022","journal-title":"J Virol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-alpha and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103179","article-title":"Hepatocellular carcinoma reduces ATXN7L3 to evade estrogen-dependent growth suppression","volume":"63","author":"Bean","year":"2021","journal-title":"EBioMedicine"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.348763","article-title":"Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs)","volume":"287","author":"Yang","year":"2012","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001932","article-title":"Estrogen receptor beta signaling in CD8(+) T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch","volume":"9","author":"Yuan","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7150\/thno.58337","article-title":"CD45RO(-)CD8(+) T cell-derived exosomes restrict estrogen-driven endometrial cancer development via the ERbeta\/miR-765\/PLP2\/Notch axis","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.canlet.2016.08.012","article-title":"G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis","volume":"382","author":"Wei","year":"2016","journal-title":"Cancer Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1481972","article-title":"GPER1 signaling restricts macrophage proliferation and accumulation in human hepatocellular carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jri.2005.07.006","article-title":"Effect of estrogen\/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women","volume":"69","author":"Stopinska-Gluszak","year":"2006","journal-title":". J Reprod Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1981570","article-title":"Downregulating testosterone levels enhance immunotherapy efficiency","volume":"10","author":"Wang","year":"2021","journal-title":"Oncoimmunology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/cells12121604","article-title":"The influence of sex hormones in liver function and disease","volume":"12","author":"Kasarinaite","year":"2023","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1677\/JME-10-0026","article-title":"Testosterone-induced permanent changes of hepatic gene expression in female mice sustained during Plasmodium chabaudi malaria infection","volume":"45","author":"Delic","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211010105","article-title":"Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection","volume":"12","author":"Salciccia","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.immuni.2022.05.012","article-title":"Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity","volume":"55","author":"Yang","year":"2022","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.04.007","article-title":"Boosting anticancer immunotherapy through androgen receptor blockade","volume":"40","author":"Pala","year":"2022","journal-title":"Cancer Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2405","article-title":"Androgen signaling contributes to sex differences in cancer by inhibiting NF-kappaB activation in T cells and suppressing antitumor immunity","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153397","article-title":"Androgen receptor signaling promotes Treg suppressive function during allergic airway inflammation. J","volume":"132","author":"Gandhi","year":"2022","journal-title":"Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800352","article-title":"Androgen and androgen receptor as enhancers of M2 macrophage polarization in allergic lung inflammation","volume":"201","author":"Becerra-Diaz","year":"2018","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.08.043","article-title":"Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt\/beta-catenin signaling","volume":"35","author":"Song","year":"2018","journal-title":"EBioMedicine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32120","article-title":"Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis","volume":"75","author":"Ren","year":"2022","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16320","article-title":"CCL5\/CCR5\/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies","volume":"115","author":"Wang","year":"2024","journal-title":"Cancer Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.007","article-title":"Cytochrome P450-mediated metabolism of estrogens and its regulation in human","volume":"227","author":"Tsuchiya","year":"2005","journal-title":"Cancer Lett"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7150\/thno.72471","article-title":"DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling","volume":"12","author":"Zhou","year":"2022","journal-title":"Theranostics"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331342","article-title":"Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8(+) T cell-mediated antitumour immunity and improves anti-PD-1 efficacy","volume":"73","author":"Cai","year":"2024","journal-title":"Gut"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328364","article-title":"Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma","volume":"72","author":"Xiong","year":"2023","journal-title":"Gut"},{"key":"B64","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12885-017-3633-6","article-title":"FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-beta\/Smad2\/3 signaling pathway","volume":"17","author":"Shi","year":"2017","journal-title":"BMC Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J Hepatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101264","article-title":"Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma","volume":"4","author":"Xing","year":"2023","journal-title":"Cell Rep Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.04.101","article-title":"Group 2 innate lymphoid cells in airway diseases","volume":"156","author":"Kato","year":"2019","journal-title":"Chest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0321","article-title":"Effect of c-neu\/ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology","volume":"66","author":"Shyamala","year":"2006","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.0c00194","article-title":"6-prenylnaringenin from hops disrupts ERalpha-mediated downregulation of CYP1A1 to facilitate estrogen detoxification","volume":"33","author":"Hitzman","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaa064","article-title":"Interplay between estrogen and Stat3\/NF-kappaB-driven immunomodulation in lung cancer","volume":"41","author":"Deng","year":"2020","journal-title":"Carcinogenesis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0267","article-title":"Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced\/activator protein-1-dependent genes","volume":"19","author":"DeNardo","year":"2005","journal-title":"Mol Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020279","article-title":"Regulation of bcl-2 family proteins in estrogen receptor-positive breast cancer and their implications in endocrine therapy","volume":"14","author":"Kawiak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/ijms20061326","article-title":"Understanding immune evasion and therapeutic targeting associated with PD-1\/PD-L1 pathway in diffuse large B-cell lymphoma","volume":"20","author":"Song","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-021-02003-w","article-title":"Estrogen\/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-23-0398","article-title":"RISING STARS: Androgens and immune cell function","volume":"261","author":"Ainslie","year":"2024","journal-title":"J Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.113741","article-title":"Role of ROS\/JAK2\/STAT3 signaling pathway in di-n-butyl phthalate-induced testosterone synthesis inhibition and antagonism of lycopene","volume":"175","author":"Wang","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2001.0900","article-title":"17-beta-estradiol suppresses IL-2 and IL-2 receptor","volume":"14","author":"McMurray","year":"2001","journal-title":"Cytokine"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.02.013","article-title":"Sex hormones, the anticancer immune response, and therapeutic opportunities","volume":"43","author":"Conforti","year":"2025","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13293-020-00301-y","article-title":"The impact of sex and gender on immunotherapy outcomes","volume":"11","author":"Klein","year":"2020","journal-title":"Biol Sex Differ"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40779-023-00484-6","article-title":"Regulatory T cells in skin regeneration and wound healing","volume":"10","author":"Knoedler","year":"2023","journal-title":"Mil Med Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4329","article-title":"TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-kappaB-IL6 signaling pathway","volume":"11","author":"Ren","year":"2016","journal-title":"Oncol Lett"},{"key":"B84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s13238-012-2104-8","article-title":"Regulation of TLR7\/9 signaling in plasmacytoid dendritic cells","volume":"4","author":"Bao","year":"2013","journal-title":"Protein Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.792721","article-title":"Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma","volume":"292","author":"Cevik","year":"2017","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217696","article-title":"Ferroptosis meets inflammation: A new frontier in cancer therapy","volume":"620","author":"Liu","year":"2025","journal-title":"Cancer Lett"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yhbeh.2016.11.017","article-title":"Sex differences in immune responses: Hormonal effects, antagonistic selection, and evolutionary consequences","volume":"88","author":"Roved","year":"2017","journal-title":"Horm Behav"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2024.12.008","article-title":"Next-generation sequencing demonstrates racial and sex differences in genomic profiling of hepatocellular carcinoma patients: an AACR GENIE project analysis","volume":"27","author":"Tsilimigras","year":"2025","journal-title":"HPB (Oxford)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.564740","article-title":"Sex-determining region Y chromosome-related high-mobility-group box 10 in cancer: A potential therapeutic target","volume":"8","author":"Yu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12672-024-01131-9","article-title":"Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma","volume":"15","author":"Huang","year":"2024","journal-title":"Discov Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31437","article-title":"Attenuating the epidermal growth factor receptor-extracellular signal-regulated kinase-sex-determining region Y-box 9 axis promotes liver progenitor cell-mediated liver regeneration in zebrafish","volume":"73","author":"So","year":"2021","journal-title":"Hepatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2017.09.013","article-title":"Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma","volume":"410","author":"Liu","year":"2017","journal-title":"Cancer Lett"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/biology12070984","article-title":"Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma","volume":"12","author":"Nevola","year":"2023","journal-title":"Biol (Basel)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16357","article-title":"Sox9\/CXCL5 axis facilitates tumour cell growth and invasion in hepatocellular carcinoma","volume":"289","author":"Ren","year":"2022","journal-title":"FEBS J"},{"key":"B96","doi-asserted-by":"publisher","first-page":"53","DOI":"10.20517\/2394-5079.2024.119","article-title":"Sex differences in hepatocellular carcinoma","volume":"10","author":"James","year":"2024","journal-title":"Hepatoma Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117538","article-title":"Race\/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study","volume":"240","author":"Oluyomi","year":"2024","journal-title":". Environ Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7150\/jca.83779","article-title":"Sex differences in the impact of metabolic dysfunction-associated fatty liver disease on the of patients with hepatocellular carcinoma after radical resection","volume":"14","author":"Huang","year":"2023","journal-title":"J Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-024-00515-w","article-title":"Deciphering the molecular interplay and tumorigenesis in hepatocellular carcinoma through insights into FBXL6 and KRAS(G12D","volume":"11","author":"Cai","year":"2024","journal-title":"). Mil Med Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40779-023-00501-8","article-title":"Elevated FBXL6 activates both wild-type KRAS and mutant KRAS(G12D) and drives HCC tumorigenesis via the ERK\/mTOR\/PRELID2\/ROS axis in mice","volume":"10","author":"Xiong","year":"2023","journal-title":"Mil Med Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:39:09Z","timestamp":1747201149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2025.1607374"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1607374","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1607374"}}